Drug Recalls News

A lack of sterility assurance has prompted Akorn Inc. to recall more than 60,000 bottles of phenylephrine hydrochloride ophthalmic solution, 2.5%. According to the October 9, 2019, US Food and Drug Administration (FDA) Enforcement Report, the recall announcement followed “out-of-specification…

Sterility concerns have prompted Pacifico National Inc. to recall all lots of unexpired bevacizumab 1.25 mg/0.05 mL 31G injection and bevacizumab 2.5 mg/0.1 ml Normject TB injection repackaged and distributed by AmEx Pharmacy. The recall was included in the September 18, 2019, US Food and Drug…

Lupin Pharmaceuticals Inc. is recalling a single lot of gatifloxacin ophthalmic solution 0.5% due to complaints of missing product labels, according to the July 24, 2019, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects gatifloxacin ophthalmic solution 0.5% in 2.5-mL…

Increasing cholesterol levels may be associated with increased risk of primary open-angle glaucoma (POAG), according to the results of a recent study. Previous research has suggested that statin use may be associated with lower risk of POAG, but results have been mixed, according to the…

The USPSTF has again recommended the use of ocular topical medication for the prevention of gonococcal ophthalmia neonatorum (GON) in all newborns. GON, which can cause corneal scarring, ocular perforation, and blindness within as little as 24 hours after birth is present in 0.2 to 1.6 per 100,000…

Increased daily intake of the polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid and docosahexaenoic acid are associated with a decreased risk of glaucoma, the results of a recent study show. To investigate the potential association between vision health and dietary intake among older…

United Exchange Corp. has launched a voluntary recall impacting 20 lots of eye wash solution after discovering the potential for microbial contamination. The manufacturer supplied products to both Rugby Laboratories (Rugby EyeWash) and Major Pharmaceuticals (Major EyeWash). What prompted the…

By Lorraine L. Janeczko NEW YORK - People who take bupropion for over one year may lower their likelihood of developing glaucoma, a new study suggests. "Data from a population-based survey of the United States suggests that bupropion use may be associated with a reduced risk of glaucoma," senior…

 Bausch & Lomb is recalling more than 1 million bottles of an ophthalmic solution. The Class III recall is due to incorrect or missing package inserts.Approximately 1.1 million bottles of tropicamide ophthalmic solution USP, 1%, packaged in a) 2 mL bottles (NDC: 24208-585-59); and b) 15 mL…

The U.S. Food and Drug Administration approved Akorn’s New Drug Application (NDA) for Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5% and 10%, the company announced Tuesday.The product is indicated to dilate the pupil, and is often used before an ocular examination or surgical procedure.…